A clear divergence in sentiment is shaping the investment case for German defense supplier Renk. While prominent hedge funds AQR Capital Management and Marshall Wace have increased their short positions, betting on further operational setbacks, the company's own CFO, Anja Mänz-Siebje, has personally bought shares following a recent price decline. This insider purchase, often viewed as a reliable confidence signal, sets the stage for a pivotal series of events starting this week.

The backdrop is a record order book valued at approximately €6.7 billion, nearly five times last year's revenue, yet the stock price tells a different story. Currently trading around €55, the share price remains roughly 36% below its 52-week high, languishing about 10% below its 200-day moving average despite a modest recovery from its March low.

A primary overhang is a specific geopolitical risk. The German government's suspension of certain arms exports to Israel directly impacts Renk, blocking deliveries of transmission systems for Merkava and Namer tanks. This jeopardizes €80 to €100 million in revenue for the current year, representing about two to three percent of total business. In response, management is executing a significant production shift, planning to move the affected manufacturing line to its existing facility in Muskegon, Michigan. The company will invest $150 million in the U.S. site by 2030, with future orders to be handled via the U.S. Foreign Military Sales program, bypassing German export controls. The goal is to ramp annual production from 200-300 transmission units to 800 by the end of 2026.

Operational performance presents a mixed picture. For the 2025 fiscal year, Renk posted strong headline figures: revenue climbed to €1.37 billion, adjusted EBIT rose about 22% to €230 million, and net profit nearly doubled to €101 million. However, cash generation disappointed. Free cash flow came in at just €67 million, with a cash conversion rate of 47%, well below the targeted 80%. Delayed customer payments and increased working capital were the culprits, contributing to a €200 million shift in revenue volume from late 2025 into the first half of 2026.

The immediate focus for investors is a series of upcoming events. Management will face pointed questions on the speed of the U.S. production ramp-up during a pre-close call on April 22 and a capital markets conference in Munich on April 23. The first concrete data point arrives with the Q1 report on May 6, which will be scrutinized for confirmation of the full-year outlook. For 2025, Renk targets revenue above €1.5 billion and adjusted EBIT between €255 and €285 million, with the board aiming for the upper half of that range.

Shareholders will also vote on a proposed dividend of €0.58 per share at the Annual General Meeting on June 10, a significant increase from the prior year. Analyst consensus suggests potential upside, with an average price target near €67, implying a roughly 25% gain from current levels. The coming weeks will determine whether the confidence of insiders and analysts can outweigh the skepticism of short-sellers.

Ad

Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.